![]() Aptinyx Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders. | ![]() XBiotech XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
| Chronos Therapeutics Chronos Therapeutics is a biotechnology company operating a semi-virtual research and development model. | ![]() Neurotech Neurotech Pharmaceuticals is a biotechnology company focused on the development of therapies for chronic eye diseases. | ![]() Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. | |
Founding Date | Founding Date 2015 | Founding Date 2005 | Founding Date 2009 | Founding Date 1995 | Founding Date 2017 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Evanston, US HQ Evanston, US | Locations Austin, US HQ | Locations Oxford, GB HQ Oxford, GB Oxford, GB | Locations Cumberland, US HQ | Locations Watertown, US HQ Cambridge, US |
Employees | Employees 635% increase | Employees 8510% decrease | Employees 2 | Employees 1203% increase | Employees 207 |
Valuation ($) | Valuation ($) 4.1 m | Valuation ($) 234.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.1 b |
Financial | |||||
Net income | Net income ($64.8m) (FY, 2022) | Net income ($45.5m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($311.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 135m | Total funding raised N/A | Total funding raised $ 13.1m | Total funding raised $ 49.1m | Total funding raised $ 197m |

XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
View companyChronos Therapeutics is a biotechnology company operating a semi-virtual research and development model.
View company
Neurotech Pharmaceuticals is a biotechnology company focused on the development of therapies for chronic eye diseases.
View company
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
View company